I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Lepik, K.
103
results:
Search for persons
X
Format
Online (103)
Mediatypes
E-Books (2)
Articles (Online) (22)
OpenAccess-fulltext (79)
Languages
german (2)
english (87)
more...
russian (9)
less...
Sorted by: Relevance
Sorted by: Year
?
1
THE OUTCOME OF GLOFITAMAB THERAPY IN PATIENTS WITH AGGRESSI..:
Fedorova, L.
;
Smykova, O.
;
Lepik, K.
...
Hematological Oncology. 41 (2023) S2 - p. 715-715 , 2023
Link:
https://doi.org/10.1002/..
?
2
P1077: HODGKIN LYMPHOMA IN PATIENTS WITH HIV: NATIONAL RETR..:
Chekalov, A.
;
Popova, M.
;
Tsygankov, I.
...
HemaSphere. 6 (2022) - p. 967-968 , 2022
Link:
https://doi.org/10.1097/..
?
3
P1080: COMPARISON OF NIVOLUMAB 40 MG EFFICACY VERSUS 3 MG/K..:
Fedorova, L.
;
Lepik, K.
;
Mikhailova, N.
...
HemaSphere. 6 (2022) - p. 970-971 , 2022
Link:
https://doi.org/10.1097/..
?
4
97P Toxicity of bispecific antibody glofitamab in patients ..:
Fedorova, L.
;
Smykova, O.
;
Chekalov, A.
...
Immuno-Oncology and Technology. 16 (2022) - p. 100201 , 2022
Link:
https://doi.org/10.1016/..
?
5
BRENTUXIMAB VEDOTIN FOR TREATMENT IN PATIENTS WITH RELAPSED..:
Ionova, T.
;
Andrievskikh, M.
;
Amdiev, A.
...
Hematological Oncology. 39 (2021) S2 - p. , 2021
Link:
https://doi.org/10.1002/..
?
6
RESPONSE TO NIVOLUMAB AS ≥3rd LINE THERAPY IN PTS WITH RELA..:
Lepik, K.
;
Mikhaylova, N.
;
Kondakova, E.
...
Hematological Oncology. 37 (2019) S2 - p. 495-495 , 2019
Link:
https://doi.org/10.1002/..
?
7
RETREATMENT WITH NIVOLUMAB IN PATIENTS WITH R/R CLASSICAL H..:
Fedorova, L.
;
Lepik, K.
;
Mikhailova, N.
...
Hematological Oncology. 37 (2019) S2 - p. 496-497 , 2019
Link:
https://doi.org/10.1002/..
?
8
TREATMENT OF RELAPSED AND REFRACTORY T‐CELL LYMPHOMAS: FIRS..:
Lepik, E.
;
Kozlov, A.
;
Borzenkova, E.
...
Hematological Oncology. 37 (2019) S2 - p. 473-474 , 2019
Link:
https://doi.org/10.1002/..
?
9
INFECTIOUS COMPLICATIONS OF NIVOLUMAB THERAPY IN RELAPSED/R..:
Rogacheva, Y.
;
Popova, M.
;
Lepik, K.
...
Hematological Oncology. 37 (2019) S2 - p. 502-502 , 2019
Link:
https://doi.org/10.1002/..
?
10
CASE SERIES OF NIVOLUMAB TREATMENT IN PATIENTS WITH RELAPSE..:
Rogacheva, Y.
;
Popova, M.
;
Nekrasova, A.
...
Hematological Oncology. 37 (2019) S2 - p. 500-502 , 2019
Link:
https://doi.org/10.1002/..
?
11
Declines in highly active antiretroviral therapy initiation..:
Lourenço, L
;
Samji, H
;
Nohpal, A
...
HIV Medicine. 16 (2015) 6 - p. 337-345 , 2015
Link:
https://doi.org/10.1111/..
?
12
Benefit Sensitivities of Adaptive Traffic Control Strategie..:
Stewart, J.A.
;
Lepik, K.
;
Van Aerde, M.
Transportation Research Record: Journal of the Transportation Research Board. 1692 (1999) 1 - p. 173-181 , 1999
Link:
https://doi.org/10.3141/..
?
13
Muscarinic (m5) receptors in the ventral tegmental area are..:
Yeomans, J.S.
;
Takeuchi, J.
;
Baptista, M.
...
Life Sciences. 60 (1997) 13-14 - p. 1203 , 1997
Link:
https://doi.org/10.1016/..
?
14
COMBINATION OF NIVOLUMAB AND BENDAMUSTINE IN PATIENTS WITH ..:
Mikhailova, N.B.
;
Lepik, K.V.
;
Kondakova, E.V.
...
Hematological Oncology. 37 (2019) S2 - p. 494-495 , 2019
Link:
https://doi.org/10.1002/..
?
15
Efficacy of Dasatinib in a CML Patient in Blast Crisis with..:
Morozova, E.V.
;
Vlasova, Y.Y.
;
Pryanishnikova, M.V.
..
Biomarker Insights. 10s3 (2015) - p. BMI.S22438 , 2015
Link:
https://doi.org/10.4137/..
1-15